Recombinant elaB is a C-tail-anchored inner membrane protein produced via genetic engineering in E. coli. Native elaB (accession: G7173, UniProt: P0AEH5) is a 101-amino-acid protein with a conserved C-terminal transmembrane domain (Fig. 1) . It plays critical roles in stress responses and persister cell regulation, distinguishing it from other stress-related toxins like TisB and GhoT .
ElaB protects E. coli against reactive oxygen species (ROS), though its mechanism differs from toxin-based stress responses . Deletion of elaB reduces survival under oxidative stress .
ElaB enhances thermal resistance by maintaining membrane integrity during heat stress. Unlike TisB/GhoT, it does not induce cell death .
| Condition | Effect of elaB Deletion |
|---|---|
| Antibiotic Stress | Increased persister formation (e.g., ciprofloxacin tolerance) |
| Stress Adaptation | Reduced resilience to oxidative/heat stress |
ElaB expression is tightly regulated by the stationary-phase sigma factor RpoS (σ³⁸) . Key findings:
| Protein | Function | Persister Impact |
|---|---|---|
| TisB | Toxin-induced dormancy | Increases persistence |
| GhoT | Membrane-disrupting toxin | Increases persistence |
| ElaB | Stress protection, membrane stability | Reduces persistence |
While direct applications of recombinant elaB are not yet documented, its roles suggest potential uses:
Antibiotic Synergy: Targeting elaB to reduce persister populations in infections.
Industrial Strain Engineering: Enhancing stress tolerance in biofuel-producing E. coli.
Biomarker Discovery: Tracking persistent infections via elaB expression profiling.
KEGG: ecj:JW2261
STRING: 316385.ECDH10B_2427
ElaB is a small protein consisting of 101 amino acids with a single transmembrane domain located at the C-terminus. This C-terminal transmembrane domain is highly conserved across several bacterial species, while the N-terminal region shows less conservation in terms of length and amino acid composition. The transmembrane domain is positioned very close to the end of the C-terminus and is followed by two to four residues containing one to three arginines .
Methodology for structural characterization:
Fusion of fluorescent proteins (mCherry or GFP) to the C-terminus of ElaB for visualization
Membrane fractionation coupled with Western blotting for localization studies
Comparison with other C-tail-anchored proteins (YqjD and YgaM) that share similar transmembrane domains
ElaB is primarily localized to the inner membrane of E. coli with particular concentration at the cell poles. This has been confirmed through multiple experimental approaches:
Chromosomal fusion of mCherry to the C-terminus of the elaB gene shows polar localization
Cell fractionation studies demonstrate that ElaB is present exclusively in the inner membrane fraction and not in the outer membrane fraction
Control experiments with known inner membrane protein MacB and outer membrane protein OmpA confirm the specificity of this localization
The expression of elaB is primarily regulated by the stationary-phase sigma factor RpoS (σ38) through direct binding to the elaB promoter:
Transcription of elaB is significantly upregulated (13.9 ± 0.2-fold) when cells enter stationary phase
Expression is also increased (9.5 ± 0.6-fold) when cells grow in nutrient-limited minimal medium compared to rich medium during exponential growth
In an rpoS deletion mutant, there is no induction of elaB in the stationary phase
Overexpression of rpoS increases elaB transcription 2.4 ± 0.1-fold during exponential growth in minimal medium
Several complementary approaches have been used to demonstrate direct regulation of elaB by RpoS:
Electrophoretic Mobility Shift Assay (EMSA): Purified RpoS in the presence of E. coli core RNA polymerase binds specifically to DNA fragments containing the RpoS binding site close to the elaB start codon (probe 2) in a dose-dependent manner
Promoter Activity Assays: Using lacZ reporter constructs, wild-type cells show significantly higher β-galactosidase activity (1,034.2 ± 34.2 Miller units) than ΔrpoS cells (268.9 ± 15.9 Miller units)
Site-Directed Mutagenesis: Altering the conserved RpoS binding site from TTCAGG (−35 region)...TCTATAGTTA (−10 region) to AAAAAA (−35 region)...CCCCCCCCCC (−10 region) abolishes RpoS regulation
Complementation Experiments: Overexpression of rpoS in ΔrpoS cells restores promoter activity when using wild-type promoter constructs but not with mutated binding sites
ElaB plays a significant role in protecting E. coli cells against multiple stress conditions:
Heat Shock: Deletion of elaB reduces survival at 65°C for 10 minutes by approximately 3.3 × 10^5-fold compared to wild-type cells
Oxidative Stress: When treated with 20 mM H₂O₂ for 10 minutes, cell survival is reduced approximately 3.6 × 10^4-fold in elaB deletion mutants
Complementation: Reintroduction of the elaB gene restores stress resistance to levels similar to wild-type in both conditions
Interestingly, ElaB decreases persister cell formation in E. coli:
Based on general principles for membrane protein expression in E. coli, the following strategies are recommended for ElaB:
Expression Vector Selection: Vectors with inducible promoters (T7, tac) and appropriate affinity tags (His, MBP) for membrane proteins
E. coli Host Strains: Specialized strains for membrane protein expression such as C41(DE3), C43(DE3), or Lemo21(DE3)
Fusion Strategies: Previous successful approaches include:
Tail-anchored membrane proteins present unique expression challenges:
Membrane Insertion: C-tail-anchored proteins like ElaB lack N-terminal signal sequences, requiring specific machinery for proper membrane targeting
Potential Toxicity: While ElaB itself does not appear to be toxic when overexpressed (unlike YqjD) , expression conditions should be carefully optimized
Solubilization Challenges: The transmembrane domain requires appropriate detergents for extraction from membranes while maintaining structure and function
Verification of Proper Folding: Functional assays are needed to confirm that recombinant ElaB retains its native activity in stress protection
ElaB provides a unique model system for studying stress response mechanisms:
Comparative Analysis: Compare elaB with paralogs YgaM and YqjD to understand functional divergence among C-tail-anchored membrane proteins
Regulatory Networks: Study the integration of RpoS-dependent regulation with other stress response pathways
Structure-Function Relationships: Investigate how the conserved transmembrane domain contributes to stress protection
Membrane Dynamics: Explore how ElaB's polar localization relates to its function in stress resistance
To investigate ElaB's role in reducing persister formation, researchers can employ:
Time-Kill Assays: Monitor survival dynamics during antibiotic treatment with multiple antibiotic classes at >10× MIC concentrations
Single-Cell Analysis: Use microfluidics combined with time-lapse microscopy to observe persister formation at the single-cell level
Transcriptional Profiling: Compare gene expression patterns between wild-type and ΔelaB strains during antibiotic exposure
Metabolic Studies: Investigate whether ElaB affects energy metabolism pathways known to be involved in persister formation
Membrane Integrity Assays: Assess whether ElaB influences membrane permeability or potential, which might affect antibiotic uptake or activity
Protocol for Heat Stress Resistance Assay:
Grow wild-type, ΔelaB, and complemented strains to the desired growth phase (typically stationary phase)
Perform serial dilutions and plate for viable count determination
Calculate survival rates compared to pre-treatment controls
Protocol for Oxidative Stress Resistance Assay:
Grow cultures to appropriate phase
Neutralize remaining H₂O₂ with catalase
Determine viable counts and calculate survival rates
Common challenges when working with ElaB include:
Detection Issues: Low natural expression levels may require sensitive detection methods. Use epitope tags and optimize Western blot conditions specifically for membrane proteins
Localization Artifacts: Overexpression may cause mislocalization. Validate with chromosomal fusions at physiological expression levels
Purification Difficulties: Optimize detergent selection for solubilization through systematic screening
Functional Assessment: Develop high-throughput assays for stress protection to facilitate mutational analysis of structure-function relationships